NY-ESO-1 Positive Tumor Cells Present
2 clinical trials · Condition
◉ Watch NY-ESO-1 Positive Tumor Cells Present
| Record | Firm | Date |
|---|---|---|
| Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma (NCT03450122) | M.D. Anderson Cancer Center | 2018-09-13 |
| TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma (NCT03506802) | Jonsson Comprehensive Cancer Center | 2018-07-10 |
Track NY-ESO-1 Positive Tumor Cells Present automatically
Every clearance here is in the API, with alerts when new ones post.